Who Owns Cadrenal Therapeutics Stock?
NASDAQ: CVKDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 9.75%
- Held by insiders
- 9.66%
- Institutional holders
- 22
- Institutions 9.7%
- Insiders 9.7%
- Public and other 80.6%
Who owns Cadrenal Therapeutics stock?
Institutional investors own about 9.7% of Cadrenal Therapeutics's shares, spread across 22 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 9.66% of CVKD.
The largest institutional holders are Vanguard Capital Management LLC (1.41%), HRT Financial LP (0.81%) and Geode Capital Management, LLC (0.53%). Together, the top 10 institutions control 3.2% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their CVKD positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CVKD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 50.14K | 1.41% | +10.9% |
| HRT Financial LP | 29.05K | 0.81% | +100.0% |
| Geode Capital Management, LLC | 19.02K | 0.53% | -12.0% |
| Vanguard Fiduciary Trust Co | 8.31K | 0.23% | 0.0% |
| Corecap Advisors, LLC | 1.28K | 0.04% | +100.0% |
| Tower Research Capital LLC (TRC) | 1.28K | 0.04% | +226.2% |
| UBS Group AG | 1.11K | 0.03% | +36966.7% |
| Grove Bank & Trust | 1.00K | 0.03% | +100.0% |
| Morgan Stanley | 706 | 0.02% | +606.0% |
| Clearstead Advisors, LLC | 650 | 0.02% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CVKD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 33.28K | 0.93% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 16.86K | 0.47% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 12.31K | 0.34% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 2.45K | 0.07% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 2.04K | 0.06% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 1.11K | 0.03% |
| Dimensional ETF Trust-Dimensional US Sustainability Core 1 ETF | 914 | 0.03% |
Frequently asked questions
Who is the largest shareholder of Cadrenal Therapeutics?
Vanguard Capital Management LLC is the largest institutional shareholder of CVKD, owning 1.41% of shares outstanding (50.14K shares) as of its latest 13F filing.
What percentage of Cadrenal Therapeutics is owned by institutions?
Institutions own about 9.7% of CVKD shares and 10.8% of the public float.
How much of Cadrenal Therapeutics do insiders own?
Insiders, such as officers and directors, own about 9.66% of CVKD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.